PRETREATMENT SERUM BETA-2-MICROGLOBULIN IN MULTIPLE-MYELOMA

被引：40

作者：

BRENNING, G

SIMONSSON, B

KALLANDER, C

AHRE, A

机构：

[1] UNIV UPPSALA,CTR BIOMED,DEPT MED VIROL,S-75123 UPPSALA,SWEDEN

[2] DANDERYD HOSP,DEPT INTERNAL MED,S-18203 DANDERYD,SWEDEN

来源：

关键词：

D O I：

10.1111/j.1365-2141.1986.tb02903.x

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：85 / 93

页数：9

共 31 条

[1] INTERMITTENT HIGH-DOSE MELPHALAN PREDNISONE VS CONTINUOUS LOW-DOSE MELPHALAN TREATMENT IN MULTIPLE-MYELOMA
AHRE, A
BJORKHOLM, M
MELLSTEDT, H
HOLM, G
BRENNING, G
ENGSTEDT, L
GAHRTON, G
HALLEN, J
JOHANSSON, B
JOHANSSON, SGO
KARNSTROM, L
KILLANDER, A
LERNER, R
LOCKNER, D
LONNQVIST, B
SIMONSSON, B
STALFELT, AM
TERNSTEDT, B
WADMAN, B
[J]. EUROPEAN JOURNAL OF CANCER & CLINICAL ONCOLOGY, 1983, 19 (04): : 499 - 506
[2] ALEXANIAN R, 1975, CANCER, V36, P1192, DOI 10.1002/1097-0142(197510)36:4<1192::AID-CNCR2820360403>3.0.CO
[3] 2-I
[4] BATAILLE R, 1984, BLOOD, V63, P468
[5] SERUM BETA-2-MICROGLOBULIN IN MULTIPLE-MYELOMA - RELATION TO PRESENTING FEATURES AND CLINICAL STATUS
BATAILLE, R
MAGUB, M
GRENIER, J
DONNADIO, D
SANY, J
[J]. EUROPEAN JOURNAL OF CANCER & CLINICAL ONCOLOGY, 1982, 18 (01): : 59 - 66
[6] SERUM BETA-2-MICROGLOBULIN AND SURVIVAL DURATION IN MULTIPLE-MYELOMA - A SIMPLE RELIABLE MARKER FOR STAGING
BATAILLE, R
DURIE, BGM
GRENIER, J
[J]. BRITISH JOURNAL OF HAEMATOLOGY, 1983, 55 (03) : 439 - 447
[7] BERGGARD I, 1968, J BIOL CHEM, V243, P4095
[8] CASSUTO JP, 1978, LANCET, V2, P108
[9] EVALUATION OF SERUM BETA-2-MICROGLOBULIN AS A PROGNOSTIC INDICATOR IN MYELOMATOSIS
CHILD, JA
CRAWFORD, SM
NORFOLK, DR
OQUIGLEY, J
SCARFFE, JH
STRUTHERS, LPL
[J]. BRITISH JOURNAL OF CANCER, 1983, 47 (01) : 111 - 114
[10] COMPLETE AMINO-ACID SEQUENCE OF BETA2-MICROGLOBULIN
CUNNINGHAM, BA
WANG, JL
BERGGARD, I
PETERSON, PA
[J]. BIOCHEMISTRY, 1973, 12 (24) : 4811 - 4822